Innoviva, Inc. (INVA)
$21.21+1.63%Close
BUYRECOVERY · day 8
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $1.6B
- Beta
- 0.33
- P/E (TTM)
- 4.28
- Short % float
- 9.89%
- Days to cover
- 5.7
- SI change
- -4.2%
- 1W
- +3.46%
- 1M
- +2.86%
- vs SPY 1W
- +2.30%
- vs SPY 1M
- -0.13%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on INVA?
- LOPJLB’s latest quantitative signal on Innoviva, Inc. (INVA) is BUY in a RECOVERY regime. Signals are updated daily.
- What market regime is INVA in?
- Innoviva, Inc. (INVA) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Innoviva, Inc. (INVA) do?
- Innoviva, Inc. functions as a pharmaceutical company, concentrating on the worldwide creation and marketing of medical treatments. Its current product lineup prominently includes several once-daily combination therapies: RELVAR/BREO ELLIPTA, which integrates vilanterol (a long-acting beta2 agonist, or LABA) with fluticasone furoate (an inhaled corticosteroid, or ICS); ANORO ELLIPTA, a medicatio…